Workflow
Fiscal Q1 2025 Revenues
PLXProtalix BioTherapeutics(PLX) GlobeNewswire·2025-01-08 06:00

Fiscal Q1 2025 Revenues Issy-les-Moulineaux, France – January 8th, 2025 A robust start to the year, in line with the Group's strategic and financial objectives Highlights Business momentum continuing to be strong in the first quarter, fueled by solid net retention and a development pipeline on track to meet full year objectivesTotal Revenues grew organically by +13.2% reaching 289 million euros in Fiscal Q1 2025, providing a solid foundation to achieve the low-double-digit growth target for the full yearOp ...